Skip to main content

Articles

Page 14 of 33

  1. To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-line platinum-based ...

    Authors: Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng…
    Citation: Journal of Ovarian Research 2021 14:12
  2. Previously anecdotally observed rebounds in follicle growth after interruption of exogenous gonadotropins in absolute non-responders were the impetus for here reported study. In a prospective cohort study, we ...

    Authors: Norbert Gleicher, Andrea Weghofer, Sarah K. Darmon and David H. Barad
    Citation: Journal of Ovarian Research 2021 14:11
  3. Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in reproductive-age women. It is one of the risk factors of metabolic syndrome (MetS). These two syndromes have an inflammatory etiologi...

    Authors: Narges Zaeemzadeh, Shahideh Jahanian Sadatmahalleh, Saeideh Ziaei, Anoshirvan Kazemnejad, Maryam Movahedinejad, Azadeh Mottaghi and Neda Mohamadzadeh
    Citation: Journal of Ovarian Research 2021 14:10
  4. Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of HIPEC, so full-dose utilization can...

    Authors: Wu-yun Wang, Miao-fang Wu, Dong-bing Wu, Li-juan Wang, Hui Li, Zhong-qiu Lin and Jing Li
    Citation: Journal of Ovarian Research 2021 14:9
  5. Ovarian cancer (OC) has the highest mortality rate in gynecologic tumors. Despite decades of continuous efforts, the survival rate of patients has not improved significantly, mostly due to drug resistance. Exo...

    Authors: Zhang Li, Wang Yan-qing, Yang Xiao, Liu Shi-yi, Yuan Meng-qin, Xian Shu, Yang Dong-yong, Zheng Ya-jing and Cheng Yan-xiang
    Citation: Journal of Ovarian Research 2021 14:7
  6. Premature ovarian failure (POF) is characterized by the loss of ovarian activity before the age of 40 years. Stem cell therapy has the capability to create a regenerative microenvironment and is a proposed tre...

    Authors: M. Mashayekhi, E. Mirzadeh, Z. Chekini, F. Ahmadi, P. Eftekhari-Yazdi, S. Vesali, T. Madani and N. Aghdami
    Citation: Journal of Ovarian Research 2021 14:5
  7. Ovarian cancer is the first leading cause of death in gynecological cancers. The continuous survival and metastasis of cancer cells are the main causes of death and poor prognosis in patients with ovarian canc...

    Authors: Jie Li, Songlin Zhang, Lei Wu, Meili Pei and Yu Jiang
    Citation: Journal of Ovarian Research 2021 14:4
  8. Ovarian responsiveness to controlled ovarian stimulation is essential for a successful clinical outcome in assisted reproductive technology (ART) cycles. We aimed to find a suitable new ovulation stimulation p...

    Authors: Xinyue Zhang, Ting Feng, Jihong Yang, Yingying Hao, Suying Li, Yan Zhang and Yun Qian
    Citation: Journal of Ovarian Research 2021 14:3
  9. Growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) genes play important roles in folliculogenesis. Altered expression of the two have been found among patients with poor ovarian resp...

    Authors: Yan Gong, Jesse Li-Ling, Dongsheng Xiong, Jiajing Wei, Taiqing Zhong and Hao Tan
    Citation: Journal of Ovarian Research 2021 14:1
  10. Although lncRNA CTBP1-AS2 has been functionally analyzed only in cardiomyocyte hypertrophy and diabetes, analysis of TCGA dataset revealed its downregulation in endometrial carcinoma (EC), indicating its invol...

    Authors: Qing-an-zi Wang, Yongxiu Yang and Xiaolei Liang
    Citation: Journal of Ovarian Research 2020 13:37

    The Retraction Note to this article has been published in Journal of Ovarian Research 2020 13:147

  11. This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-020-00754-0.

    Authors: Qing-an-zi Wang, Yongxiu Yang and Xiaolei Liang
    Citation: Journal of Ovarian Research 2020 13:147

    The original article was published in Journal of Ovarian Research 2020 13:37

  12. Epithelial ovarian carcinoma (EOC) is a genetically heterogeneous disease that is partly driven by molecular defects in mismatch repair (MMR) or homology-directed DNA repair (HDR). Ribonuclease H2 serves to re...

    Authors: Rahel Polaczek, Peter Schürmann, Lisa-Marie Speith, Robert Geffers, Matthias Dürst, Peter Hillemanns, Tjoung-Won Park-Simon, Clemens Liebrich and Thilo Dörk
    Citation: Journal of Ovarian Research 2020 13:146
  13. GAS5 contains a hormone response element that can induce cell apoptosis in breast cancer. It is known that cell apoptosis and hormone response play crucial roles in polycystic ovary syndrome (PCOS), indicating...

    Authors: Chunxia Wang, Shishi Yue, Yaru Jiang, Yanjia Mao, Zhijing Zhao, Xinwei Liu, Xiaoqian Zhang, Dongxu Pei and Yongwei Li
    Citation: Journal of Ovarian Research 2020 13:145
  14. This study aimed to explore whether the dysregulation of lnc-small nucleolar RNA host gene 1 (SNHG1) and miR-216b-5p correlated with chemoresistance and indicated poor prognosis of serous epithelial ovarian ca...

    Authors: Mei Li Pei, Zong Xia Zhao and Ting Shuang
    Citation: Journal of Ovarian Research 2020 13:144
  15. Patients with ovarian clear cell carcinoma (OCCC) have a poor prognosis because they show low sensitivity to platinum-based chemotherapy. New treatments for refractory OCCC are urgently needed.

    Authors: Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai and Lu-Te Chang
    Citation: Journal of Ovarian Research 2020 13:143
  16. Epithelial ovarian cancer (EOC) has the worst prognosis in all of gynecologic malignant tumors because of its high recurrence and eventually chemo-resistance. Early diagnosis of recurrence is crucial to avoid ...

    Authors: Lin Xiao, Junying Tang, Wenbo Li, Xuexun Xu and Hao Zhang
    Citation: Journal of Ovarian Research 2020 13:141
  17. Currently, the world is in the seventh month of the COVID-19 pandemic. Globally, infections with novel SARS-CoV-2 virus are continuously rising with mounting numbers of deaths. International and local public h...

    Authors: Mitko Madjunkov, Michal Dviri and Clifford Librach
    Citation: Journal of Ovarian Research 2020 13:140
  18. Exposure of oocytes to the endometrioma fluid has an adverse effect on embryonic quality. To determine whether adding transferrin and antioxidants to culture medium could counteract detrimental effects on mous...

    Authors: Zi Ren, Jiana Huang, Chuanchuan Zhou, Lei Jia, Manchao Li, Xiaoyan Liang and Haitao Zeng
    Citation: Journal of Ovarian Research 2020 13:139
  19. Premature ovarian failure is one of the major side effects of chemotherapy drugs. Blood plasma contains several factors that might lead to the repair of different tissues.

    Authors: Soghra Bahmanpour, Eisa Moradiyan, Farzaneh Dehghani and Nehleh Zarei-fard
    Citation: Journal of Ovarian Research 2020 13:138
  20. Male sex and older age have been reported to be associated with worse outcomes from COVID-19. It was postulated that estrogens may play a role in reducing the severity of the disease and may therefore offer a ...

    Authors: Jacob O’Brien, Kevin Y. Du and Chun Peng
    Citation: Journal of Ovarian Research 2020 13:137

    The Correction to this article has been published in Journal of Ovarian Research 2021 14:58

  21. In mammals, it is known that the estradiol-17β (E2) is mainly synthetized in ovarian granulosa cells (GCs), and the excessive apoptosis of GCs induces the follicular atresia. Many studies have implicated the e...

    Authors: Yao Jiang, Xiaoping Xin, Xiangchun Pan, Ailing Zhang, Zhe Zhang, Jiaqi Li and Xiaolong Yuan
    Citation: Journal of Ovarian Research 2020 13:135
  22. With increasing cases of iatrogenic premature ovarian insufficiency (POI), more clinicians are required to counsel patients regarding the gonadotoxic effects of iatrogenic treatments. This survey aimed to expl...

    Authors: Yanfang Wang, Ying Zou, Wei Wang, Qingmei Zheng, Ying Feng, Han Dong, Zhangyun Tan, Xiaoqin Zeng, Yinqing Zhao, Danhong Peng, Xiaomin Yang and Aijun Sun
    Citation: Journal of Ovarian Research 2020 13:134
  23. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Zixuan Gao, Xiaochen Ma, Jing Liu, Yuhang Ge, Lei Wang, Ping Fu, Zhian Liu, Ruiqin Yao and Xiaonan Yan
    Citation: Journal of Ovarian Research 2020 13:133

    The original article was published in Journal of Ovarian Research 2020 13:106

  24. Cervical cancer is one of the most common female malignancy that occurs worldwide and is reported to cause over 300,000 deaths in 2018. Autophagy controls the survival and death of cancerous cells by regulatin...

    Authors: Hengyu Chen, Qingchun Deng, Wenwen Wang, Huishan Tao and Ying Gao
    Citation: Journal of Ovarian Research 2020 13:131
  25. Gynecological cancers are among the leading causes of cancer-associated mortality worldwide. While the number of cases are rising, current therapeutic approaches are not efficient enough. There are considerabl...

    Authors: Mohammad Hossein Pourhanifeh, Maryam Darvish, Javad Tabatabaeian, Mahboobeh Rabbani Fard, Reza Mottaghi, Mohammad Javad Azadchehr, Moghaddaseh Jahanshahi, Amirhossein Sahebkar and Hamed Mirzaei
    Citation: Journal of Ovarian Research 2020 13:130
  26. Metastasis to the ovary from nongynecologic organs accounts for 9% of all ovarian malignancies. Although the most common nongynecologic primary site of ovarian metastasis is the gastrointestinal tract, metasta...

    Authors: Jing-Jing Zhang, Dong-Yan Cao, Jia-Xin Yang and Keng Shen
    Citation: Journal of Ovarian Research 2020 13:128
  27. Long non-coding RNA PTPRG antisense RNA 1 (PTPRG-AS1) deregulation has been reported in various human malignancies and identified as an important modulator of cancer development. Few reports have focused on th...

    Authors: Juanjuan Shi, Xijian Xu, Dan Zhang, Jiuyan Zhang, Hui Yang, Chang Li, Rui Li, Xuan Wei, Wenqing Luan and Peishu Liu
    Citation: Journal of Ovarian Research 2020 13:127
  28. This study aimed to explore the effects of activating GABAB1 receptor by baclofen on proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) of ovarian cancer cells.

    Authors: Jun Gao, Yao Gao, Shixin Lin, Xia Zou, Yukai Zhu, Xintong Chen, Hong Wan and Hong Zhu
    Citation: Journal of Ovarian Research 2020 13:126
  29. High-grade serous ovarian cancer (HGSOC) is the most common and lethal subtype of ovarian cancer. A growing body of evidence suggests tumor-supporting roles of several members of the kallikrein-related peptida...

    Authors: Weiwei Gong, Yueyang Liu, Eleftherios P. Diamandis, Marion Kiechle, Holger Bronger, Julia Dorn, Tobias Dreyer and Viktor Magdolen
    Citation: Journal of Ovarian Research 2020 13:125
  30. Ovarian cancer is the eighth most commonly occurring cancer in women. Clinically, the limitation of conventional screening and monitoring approaches inhibits high throughput analysis of the tumor molecular mar...

    Authors: Mina Sharbatoghli, Somayeh Vafaei, Hamidreza Aboulkheyr Es, Mohsen Asadi-Lari, Mehdi Totonchi and Zahra Madjd
    Citation: Journal of Ovarian Research 2020 13:124
  31. Ovarian clear cell carcinoma (OCCC) is a rare histologic type of ovarian cancer. There is a lack of an efficient prognostic predictive tool for OCCC in clinical work. This study aimed to construct and validate...

    Authors: Qian Chen, Shu Wang and Jing-He Lang
    Citation: Journal of Ovarian Research 2020 13:123
  32. MicroRNAs (MiRNAs) is thought to play a critical role in the initiation and progress of ovarian cancer (OC). Although miRNAs has been widely recognized in ovarian cancer, the role of hsa-miR-30a-5p (miR-30a) in.....

    Authors: Weijia Lu, Yunyu Wu, Can Xiong Lu, Ting Zhu, Zhong Lu Ren and Zhiwu Yu
    Citation: Journal of Ovarian Research 2020 13:120
  33. Wilms tumor 1 associated protein (WTAP) modulates other genes via transcriptional and post-transcriptional regulation, in particular, by acting as a N6-methyladenosine writer or binding to the 3’UTR of mRNA, a...

    Authors: Jing Wang, Jing Xu, Ke Li, Yunke Huang, Yilin Dai, Congjian Xu and Yu Kang
    Citation: Journal of Ovarian Research 2020 13:119
  34. The second major cause of death is cancer. In fact, the effectiveness of anticancer treatments and positive long-term prognosis for young women has increased. However, the problem of post-cancer infertility pl...

    Authors: Vladimir Isachenko, Bernd Morgenstern, Plamen Todorov, Evgenia Isachenko, Peter Mallmann, Bettina Hanstein and Gohar Rahimi
    Citation: Journal of Ovarian Research 2020 13:118
  35. The foundation of modern ovarian cancer care is cytoreductive surgery to remove all macroscopic disease (R0). Identification of R0 resection patients may help individualise treatment. Machine learning and AI h...

    Authors: Alexandros Laios, Alexandros Gryparis, Diederick DeJong, Richard Hutson, Georgios Theophilou and Chris Leach
    Citation: Journal of Ovarian Research 2020 13:117
  36. Ovarian cancer is the second fatal malignancy of the female reproductive system. Based on the cancer stem cell (CSC) theory, its poor prognosis of ovarian cancer attributed to tumor recurrence caused by CSCs. ...

    Authors: Xiaoxiao Zhang, Yue Su, Xue Wu, Rourou Xiao, Yifan Wu, Bin Yang, Zhen Wang, Lili Guo, Xiaoyan Kang and Changyu Wang
    Citation: Journal of Ovarian Research 2020 13:116
  37. The loss of ovarian function in women, referred to as premature ovarian insufficiency (POI), is associated with a series of concomitant diseases. POI is genetically heterogeneous, and in most cases, the etiolo...

    Authors: Hongli Liu, Xiaoli Wei, Yanwei Sha, Wensheng Liu, Haijie Gao, Jin Lin, Youzhu Li, Yaling Tang, Yifeng Wang, Yanlong Wang and Zhiying Su
    Citation: Journal of Ovarian Research 2020 13:114
  38. To assess the anti-tumor activity and side effects of different dosages of paclitaxel (albumin binding type) (hereinafter referred to as nab-P) combined with Apatinib (hereinafter referred to as AP) in platinu...

    Authors: Hong Zhao, Rong Li, Xiaoyan Wang, Xin Lu, Min Hu, Jinbin Zhang, Xia Zhao, Xiaoqin Song and Yangyang Liu
    Citation: Journal of Ovarian Research 2020 13:113

    The Retraction Note to this article has been published in Journal of Ovarian Research 2021 14:37

  39. In this study we aimed to identify a prognostic signature in BRCA1/2 mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gyn...

    Authors: Yinglian Pan, Li Ping Jia, Yuzhu Liu, Yiyu Han, Qian Li, Qin Zou, Zhongpei Zhang, Jin Huang and Qingchun Deng
    Citation: Journal of Ovarian Research 2020 13:112
  40. RNA methylation can reverse the methylation modification at the RNA level, which is an extremely important epigenetic modification. The function and mechanism of YTHDF2, as a reader of m6A modification, in epi...

    Authors: Jie Li, Lei Wu, Meili Pei and Yun Zhang
    Citation: Journal of Ovarian Research 2020 13:111

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.